Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study
Cancer Medicine · 2026
DOI: 10.1002/cam4.72174 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Suraj Manohar Rajan und 10 weiteren Autor:innen. Beteiligte Einrichtung: UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science, San Diego, California, USA. Hauptthemen laut MEDLINE: Neoplasms, Anxiety, Depression. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Depression and anxiety are common among individuals with cancer and are associated with adverse outcomes; however, the frequency, timing, and disparities of anxiety and depression diagnoses following cancer diagnosis remain incompletely characterized.
Methods
We conducted a retrospective, multi‐center cohort study of 1,161,370 adults diagnosed with one of 10 common cancers between 2015 and 2025 within the University of California Health system using electronic health record data. Patients with depression or anxiety diagnoses in the year prior to cancer diagnosis were excluded. Incident anxiety and depression diagnoses were identified following cancer diagnosis. Fine–Gray competing risk regression models were used to examine factors associated with psychiatric diagnosis while accounting for death as a competing event.
Results
Overall, 22.2% of patients received a new anxiety or depression diagnosis after cancer diagnosis, including anxiety only (8.4%), depression only (5.7%), and comorbid depression and anxiety (8.2%). Although many diagnoses occurred within the first year, a substantial proportion were identified later. Female patients had higher hazards of depression, anxiety, and comorbid diagnoses compared with males. Asian patients had lower hazards across outcomes, while Hispanic or Latino patients and Medicaid‐insured patients had higher hazards compared with reference groups. Timing varied by cancer type, with pancreatic cancer associated with the shortest time to diagnosis and prostate cancer with the longest.
Conclusions
Incident depression and anxiety affect more than one in five patients following cancer diagnosis, with marked disparities by sociodemographic factors and cancer type. Delayed diagnoses highlight the need for longitudinal and equitable mental health screening throughout the cancer care continuum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science, San Diego, California, USA.
- Center for Health Equity Education and Research, University of California, San Diego, California, USA.
- Department of Radiation Medicine & Applied Sciences, University of California, San Diego, California, USA.
- San Diego State University, San Diego, California, USA.
ORCID-Profile: Suraj Manohar Rajan, Carol Y Ochoa-Dominguez, Joshua Demb, Melody K Schiaffino, Edmund Qiao, Tyler Seibert, Brent Rose, Matthew P Banegas
Zitieren
APA
Rajan, S. M., Tran, V., Lee, A. J., Ochoa-Dominguez, C. Y., Demb, J., Schiaffino, M. K., Qiao, E., Seibert, T., Murphy, J., Rose, B., & Banegas, M. P. (2026). Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.72174
Vancouver
Rajan SM, Tran V, Lee AJ, Ochoa-Dominguez CY, Demb J, Schiaffino MK, et al. Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study. Cancer Medicine. 2026. doi:10.1002/cam4.72174
BibTeX
@article{Rajan2026,
author = {Rajan, Suraj Manohar and Tran, Vivian and Lee, Aaron-John and Ochoa-Dominguez, Carol Y and Demb, Joshua and Schiaffino, Melody K and Qiao, Edmund and Seibert, Tyler and Murphy, James and Rose, Brent and Banegas, Matthew P},
title = {Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72174}
}
EUVIMED